{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/decoy-therapeutics-regains-compliance-with-nasdaq-minimum-bid-price-requirement-302732823.html", "message": "News view counter 642274 successfully enlarged"}